GlassScriptPhysician profile
Aleksandra Stjepanovic
NPI 1093976235
$1,328.68
in general payments reported to CMS, 2019-2025
20 companies · $634 in 2025
The $634 reported for 2025 was more than what 96% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.31 · 2020: $112 · 2021: $86.35 · 2022: $109 · 2023: $131 · 2024: $168 · 2025: $634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $934.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $933.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $282.06 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Glaxosmithkline, LLC. | $230.98 | 2019-2025 | Bexsero, Pediarix, Rotarix |
| Cranial Technologies, INC | $130.30 | 2019-2022 | |
| Greer Laboratories, INC. | $109.81 | 2025 | Oralair |
| Sobi, INC | $86.58 | 2021-2023 | |
| Cumberland Pharmaceuticals, INC. | $60.66 | 2024-2025 | Kristalose |
| Kyowa Kirin, INC. | $60.13 | 2025 | |
| Phadia US INC. | $58.69 | 2019-2024 | Immunocap |
| Seqirus USA INC | $44.61 | 2023-2025 | Flucelvax Quadrivalent, Flucelvax |
| Sanofi Pasteur INC. | $41.14 | 2021-2023 | |
| Pfizer INC. | $39.57 | 2020-2025 | |
| Baxter Healthcare | $31.74 | 2024 | Hillrom - Monarch Airway Clearance System |
| Sanofi-Aventis U.S. LLC | $26.79 | 2024 | |
| Ultragenyx Pharmaceutical INC. | $22.46 | 2024 | Crysvita |
| Ironshore Pharmaceuticals INC. | $21.77 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $21.75 | 2025 | Jornay Pm |
| Tris Pharma INC | $17.96 | 2025 | Dyanavel Xr |
| Kowa Pharmaceuticals America, INC. | $15.32 | 2025 | Zoryve |
| Verrica Pharmaceuticals INC. | $15.31 | 2025 | Ycanth |
| Merck Sharp & Dohme LLC | $11.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aleksandra Stjepanovic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.